journal article·2016-02Open access

Evaluation of fluorogenic aminonaphthalenesulfonamides and 6-hydrazinobenz[de]isoquinoline-1,3-diones for the detection of bacteria

Jia Lin Luo, Terry Jin, Linda Váradi, John D. Perry, David E. Hibbs, Paul W. Groundwater

Dyes and Pigments· Volume 125

Abstract

New fluorogenic enzyme substrates were synthesized by the coupling of aminonaphthalenesulfonamides or 6-hydrazinobenz[de]isoquinoline-1,3-diones with β-alanine. The 6-hydrazinobenz[de]isoquinoline-1,3-diones were also condensed with a range of aryl aldehydes to give the corresponding hydrazones. The photophysical properties of the synthesized amines and hydrazines and their amide, hydrazide and hydrazone derivatives, were examined and they were also incorporated into Columbia agar in order to determine their potential for the detection of pathogenic bacteria.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Antifungal resistance and susceptibility · Pneumocystis jirovecii pneumonia detection and treatment · Cancer therapeutics and mechanisms

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (27)

Show source-provided references
1. Scott · 2009
2. Preventing healthcare-associated infection: risks, healthcare systems and behaviour10.1111/j.1445-5994.2009.02004.x ↗
3. Antimicrobial resistance: a global view from the 2013 world healthcare-associated infections forum10.1186/2047-2994-2-31 ↗
4. Safer use of antimicrobials in hospitals: the value of antimicrobial usage data10.5694/j.1326-5377.2010.tb04026.x ↗
5. 2012 · 120
6. Rapid clinical bacteriology and its future impact10.3343/alm.2013.33.1.14 ↗
7. Synthesis and testing of chromogenic phenoxazinone substrates for beta-alanyl aminopeptidase10.1039/b716978g ↗
8. Anderson · 2012
9. Development and evaluation of a chromogenic agar medium for methicillin-resistant Staphylococcus aureus10.1128/JCM.42.10.4519-4523.2004 ↗
10. Evaluation of a novel chromogenic agar medium for isolation and differentiation of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis isolates10.1128/JCM.02116-06 ↗
11. Prevalence of faecal carriage of Enterobacteriaceae with NDM-1 carbapenemase at military hospitals in Pakistan, and evaluation of two chromogenic media10.1093/jac/dkr299 ↗
12. Synthesis and evaluation of fluorogenic 2-amino-1,8-naphthyridine derivatives for the detection of bacteria10.1039/c2ob06986e ↗
13. Aminonaphthalenesulfonamides, a new class of modifiable fluorescent detecting groups and their use in substrates for serine protease enzymes10.1021/bi00138a023 ↗
14. Synthesis and use of 4-peptidylhydrazido-N-hexyl-1,8-naphthalimides as fluorogenic histochemical substrates for dipeptidyl peptidase IV and tripeptidyl peptidase I10.1016/j.ejmech.2008.02.036 ↗
15. Fluorescent markers for hypoxic cells: a study of nitroaromatic compounds, with fluorescent heterocyclic side chains, that undergo bioreductive binding10.1021/jm00111a049 ↗
16. A new prodrug-derived ratiometric fluorescent probe for hypoxia: high selectivity of nitroreductase and imaging in tumor cell10.1021/ol102975t ↗
17. Anthony · 2014
18. Caffeoyl naphthalenesulfonamide derivatives as HIV integrase inhibitors10.1016/S0968-0896(03)00372-9 ↗
19. Guan · 2004
20. Design and synthesis of some 1,8-naphthalimides as fluorescence probes for transition metal ions
21. Assessment of the sequence dependency for the binding of 2-aminonaphthyridine to the guanine bulge10.1016/S0968-0896(03)00026-9 ↗
22. Detection of apoptosis by PET/CT with the diethyl ester of [¹⁸F]ML-10 and fluorescence imaging with a dansyl analogue10.1016/j.bmc.2013.11.019 ↗
23. 1,8-Naphthalimides for non-doping OLEDs: the tunable emission color from blue, green to red10.1016/S1010-6030(03)00381-2 ↗
24. Serratia marcescens in a general hospital
25. Group X aldehyde dehydrogenases of Pseudomonas aeruginosa PAO1 degrade hydrazones10.1128/JB.06590-11 ↗
26. Variations in organism-specific severe sepsis mortality in the United States: 1999–200810.1097/CCM.0000000000000555 ↗
27. Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes10.1586/eri.12.50 ↗